Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Risk of tuberculosis is higher with anti–tumor necrosis f... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
0
Authors
Florence Tubach
17 more
Florence Tubach
•
Dominique Salmon
15 more
•
Xavier Mariette
Published
June 29, 2009
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Arthritis & Rheumatism
Topics
Physics
Optics
Medicine
Immunology
Pathology
Show all topics
DOI
10.1002/art.24632
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Arthritis & Rheumatism
Topics
Physics
Optics
Medicine
Immunology
Pathology
Show all topics
DOI
10.1002/art.24632
Other Formats
PDF
